Transporter-dependent drugs are affected by PXR-induced expression of MDR1 (ABCB1) and MRP2 (ABCC2), regulating the enterohepatic circulation and biliary excretion of digoxin, as well as the hepatic concentration and myopathy risk of statins (via OATP1B1 transport). Here, ABCC2 is linked to myopathy.